Discover why Bristol-Myers Squibb (BMY) is a strong buy in 2024—undervalued, high dividend, and robust strategies for ...
Meta Platforms (META) is slashing jobs at its superintelligence unit by 600 positions, according to a report by Axios on Wednesday, citing an internal memo.
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈